Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.

Cohn J, von Schoen-Angerer T, Jambert E, Arreghini G, Childs M.

J Public Health Policy. 2013 Jan;34(1):22-30. doi: 10.1057/jphp.2012.53. Epub 2012 Nov 22.

PMID:
23172047
[PubMed - indexed for MEDLINE]
2.

Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.

Weigmann K.

EMBO Rep. 2013 Jul;14(7):597-600. doi: 10.1038/embor.2013.82. Epub 2013 Jun 14. No abstract available.

PMID:
23764922
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

How to achieve international action on falsified and substandard medicines.

Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M.

BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381. No abstract available.

PMID:
23149211
[PubMed - indexed for MEDLINE]
4.

Stemming the global trade in falsified and substandard medicines.

Gostin LO, Buckley GJ, Kelley PW.

JAMA. 2013 Apr 24;309(16):1693-4. doi: 10.1001/jama.2013.3048. No abstract available.

PMID:
23579391
[PubMed - indexed for MEDLINE]
5.

Combatting substandard and falsified medicines: a view from Rwanda.

Binagwaho A, Bate R, Gasana M, Karema C, Mucyo Y, Mwesigye JP, Biziyaremye F, Nutt CT, Wagner CM, Jensen P, Attaran A.

PLoS Med. 2013;10(7):e1001476. doi: 10.1371/journal.pmed.1001476. Epub 2013 Jul 2. No abstract available.

PMID:
23843747
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.

Mackey TK, Liang BA.

BMC Med. 2013 Oct 31;11:233. doi: 10.1186/1741-7015-11-233.

PMID:
24228892
[PubMed - indexed for MEDLINE]
Free Article
7.

Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain.

Tremblay M.

Curr Drug Saf. 2013 Feb;8(1):43-55.

PMID:
23656447
[PubMed - indexed for MEDLINE]
8.

European union has the falsified medicines directive.

Taaffe T.

BMJ. 2012 Dec 20;345:e8356. doi: 10.1136/bmj.e8356. No abstract available.

PMID:
23256949
[PubMed - indexed for MEDLINE]
9.

The need for coordinated action against falsified and substandard medicines.

Seear M.

Int J Tuberc Lung Dis. 2013 Mar;17(3):286. doi: 10.5588/ijtld.12.0988. No abstract available.

PMID:
23407216
[PubMed - indexed for MEDLINE]
10.

[Counterfeit drugs as a gobal threat to health].

Golocorbin Kon S, Mikov M.

Med Pregl. 2011 May-Jun;64(5-6):285-90. Review. Serbian.

PMID:
21789919
[PubMed - indexed for MEDLINE]
11.

Counterfeit medicines in Cambodia--possible causes.

Khan MH, Okumura J, Sovannarith T, Nivanna N, Nagai H, Taga M, Yoshida N, Akazawa M, Tanimoto T, Kimura K.

Pharm Res. 2011 Mar;28(3):484-9. doi: 10.1007/s11095-010-0289-1. Epub 2010 Oct 1. No abstract available.

PMID:
20886264
[PubMed - indexed for MEDLINE]
12.

Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.

Bate R, Jensen P, Hess K, Mooney L, Milligan J.

Int J Tuberc Lung Dis. 2013 Mar;17(3):308-11. doi: 10.5588/ijtld.12.0355. Epub 2013 Jan 14.

PMID:
23321423
[PubMed - indexed for MEDLINE]
14.

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011).

Almuzaini T, Sammons H, Choonara I.

BMJ Open. 2013 Jul 24;3(7). pii: e002924. doi: 10.1136/bmjopen-2013-002924. Print 2013.

PMID:
23883882
[PubMed]
Free PMC Article
15.

Countering the Problem of Falsified and Substandard Drugs.

Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health, Institute of Medicine; Buckley GJ, Gostin LO, editors.

Washington (DC): National Academies Press (US); 2013 May 20.

PMID:
24872973
[PubMed]
Books & Documents
16.

Assessing the problem of counterfeit medications in the United Kingdom.

Jackson G, Patel S, Khan S.

Int J Clin Pract. 2012 Mar;66(3):241-50. doi: 10.1111/j.1742-1241.2011.02826.x. Epub 2011 Nov 9. Review.

PMID:
22070229
[PubMed - indexed for MEDLINE]
17.

Médecins Sans Frontières (MSF) antiretroviral treatment projects worldwide.

[No authors listed]

GMHC Treat Issues. 2003 Jul-Aug;17(7-8):7. No abstract available.

PMID:
14686313
[PubMed - indexed for MEDLINE]
18.

Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.

Khan MH, Akazawa M, Dararath E, Kiet HB, Sovannarith T, Nivanna N, Yoshida N, Kimura K.

BMC Health Serv Res. 2011 Nov 11;11:306. doi: 10.1186/1472-6963-11-306.

PMID:
22074046
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.

Tadeg H, Berhane Y.

East Afr J Public Health. 2012 Jun;9(2):85-9. Review.

PMID:
23139963
[PubMed - indexed for MEDLINE]
20.

Fraudulent and substandard medicines: getting away with murder?

Edwards IR.

Drug Saf. 2011 Jun 1;34(6):445-8. doi: 10.2165/11592370-000000000-00000. No abstract available.

PMID:
21585218
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk